heart failure
Polygenic Risk Score Shows Promise Predicting Beta Blocker Response in Heart Failure Patients
Premium
Researchers from Henry Ford Health in Detroit hope to prospectively validate the pharmacogenomics PRS's ability to predict survival benefit for patients on beta blockers.
Cardior Pharmaceuticals MicroRNA PCR Kit Receives CE Marking
The kit measures circulating levels of miR-132 in patients receiving Cardior's experimental inhibitor of that microRNA to help treat heart failure patients.
Single-Cell Transcriptomics Study Highlights Heart Failure Features Specific to Genotype
Researchers used single-nucleus RNA-seq to see heart failure-related shifts in cell populations and gene expression, including those coinciding with specific pathogenic variants.
Global, Local Polynesian Ancestry Influence Disease Risk Among Native Hawaiians
Polynesian ancestry — encompassing genetic and lifestyle factors — affects obesity, type 2 diabetes, and heart failure among Native Hawaiians, a new study has found.
Hypertrophic Cardiomyopathy Studies Reveal Common Contributors, Risk Score
Genome-wide association studies offer a look at the rare and common contributors to the heart condition, pointing to possible prediction and treatment tools.